# NextSource Biotechnology

Source: https://onco.cc/companies/nextsource-biotechnology/  
OnCo record `nextsource-biotechnology` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

NextSource Biotechnology is the Florida specialty pharma that sells lomustine in the United States as Gleostine, the nitrosourea chemotherapy used in brain tumours and Hodgkin lymphoma.

## Summary

NextSource Biotechnology is a Miami-based specialty pharmaceutical company. It acquired US rights to lomustine (formerly CeeNU) and markets it as Gleostine, a capsule alkylating agent approved for brain tumours after surgery and radiotherapy and for Hodgkin lymphoma after other treatments. The company drew attention for steep price increases on the drug after the acquisition.

## Fields

- Kind: Company
- Last checked: 2026-09-17
- Also known as: NextSource Biotechnology, LLC; NextSource Pharma
- Tags: drug-maker
- HQ: Miami, Florida
- Type: pharma

## Connected records

- drugs: [Lomustine (CCNU)](https://onco.cc/drugs/lomustine/)

---
JSON: https://onco.cc/api/v1/entities/nextsource-biotechnology.json